Indications
Therapeutic Asset Ratings
3,186 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
a2b543
Non-Small Cell Lung Carcinoma
A2 Biotherapeutics Inc.
P1/2
CC
(41)
a2b694
Cancer
A2 Biotherapeutics Inc.
P1/2
CC
(41)
a2b694
Colon Carcinoma
A2 Biotherapeutics Inc.
P1/2
CC
(41)
a2b694
Lung Cancer
A2 Biotherapeutics Inc.
P1/2
CC
(41)
a2b694
Non-Small Cell Lung Carcinoma
A2 Biotherapeutics Inc.
P1/2
CC
(41)
Adoptive Therapy With Autologous Mc2 Tcr T Cells
Melanoma
Erasmus Medical Center
P1/2
CC
(41)
Afnt-211
Pancreatic Ductal Adenocarcinoma
Affini-T Therapeutics, Inc.
P1/2
CC
(41)
Allogeneic Genetically Modified Gamma-Delta T Cells
Glioblastoma
In8bio Inc.
P1/2
CC
(41)
Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells
Multiple Sclerosis
Ever Supreme Bio Technology Co., Ltd.
P1/2
CC
(41)
Alzn002
Alzheimer Disease
Alzamend Neuro, Inc.
P1/2
CC
(41)
Amt-116 Car-T Cells
Head And Neck Squamous Cell Carcinoma
Beijing Immunochina Medical Science & Technology Co., Ltd.
P1/2
CC
(41)
Amt-116 Car-T Cells
Melanoma
Beijing Immunochina Medical Science & Technology Co., Ltd.
P1/2
CC
(41)
Amt-253 Car-T Cells
Head And Neck Squamous Cell Carcinoma
Beijing Immunochina Medical Science & Technology Co., Ltd.
P1/2
CC
(41)
Amt-253 Car-T Cells
Melanoma
Beijing Immunochina Medical Science & Technology Co., Ltd.
P1/2
CC
(41)
Anti-Hcd70 Car Transduced Pbl
Melanoma
National Cancer Institute (NCI)
P1/2
CC
(41)
Anti-Kras G12V Mtcr Pbl
Colon Carcinoma
National Cancer Institute (NCI)
P1/2
CC
(41)
Anti-Kras G12V Mtcr Pbl
Gastric Cancer
National Cancer Institute (NCI)
P1/2
CC
(41)
Armored And Gpc3-Targeted Autologous Car T-Cell
Hepatocellular Carcinoma
Shanghai AbelZeta Ltd.
P1/2
CC
(41)
Autologous Cd1C+ /Cd141+ Mydc
Glioblastoma
Universitair Ziekenhuis Brussel
P1/2
CC
(41)
Autologous Hucd19 Car T Cells
Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
P1/2
CC
(41)
Autologous Human Cd34+ Hematopoietic Stem/Precursor Cells (Hspcs), Obtained From Peripheral Blood By Leukapheresis From Plerixaformobilized Sickle Cell Disease (Scd) Patients Or Granulocyte Colony Stimulating Factor (G-Csf) And Plerixafor-Mobilized Transfusion Dependent Betathalassemia (Tdt) Patients, Genetically Modified Ex Vivo By Crispr/Cas12A (Clustered Regularly Interspaced Palindromic Repeats/Modified Acidaminococcus Sp. Cas12A) Endonuclease Complexed With A Guide Rna (Grna) That Targets The Ccaat-Box Region Of Both Gamma Globin Gene (Hbg1 And Hgb2) Promoters On Chromosome 11, Creating Indels That Disrupt Repressor Binding And Increase Gamma Globin Expression. The Editing Components Are Introduced Into The Target Cell Population As A Ribonucleoprotein Complex By Electroporation. The Cell Suspension Is Enriched For Cd34+ Cells Using Magnetic Bead Separation. Following Electroporation, The Cells Are Cultured In Media Containing Thrombopoietin, Fms-Related Tyrosine Kinase 3 Ligand (Flt3L), And Stem Cell Factor (Scf). The Substance Consists Of Cells With ?70% Cd34/Cd45+ Purity And ?70% On-Target Editing.
Sickle Cell Disease
Editas Medicine, Inc.
P1/2
CC
(41)
Autologous T Cells Obtained From Peripheral Blood Mononuclear Cells By Leukapheresis, Transduced With A Self-Inactivating, Nonreplicating Lentiviral Vector, Encoding A T Cell Chimeric Antigen Receptor Targeting Cd19. The Expressed Transgene Comprises A Cd8? Leader Sequence, A Murine Anti-Cd19 Single Chain Variable Fragment (Scfv) Derived From The Mouse Hybridoma Fmc63, A Cd8? Hinge And Transmembrane Region, And A 4-1Bb (Cd137) And Cd3? (Tcr?) Signaling Domain And Is Under Control Of The Elongation Factor 1 Alpha (Ef1?) Promoter. The Construct Is Flanked By 5' And 3' Long Terminal Repeats (Ltrs) And Also Contains A ? Packaging Signal, A Rev Response Element (Rre), A Central Polypurine Tract (Cppt) Sequence And An Optimized Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element (Wpre). The Leukapheresis Material Is Enriched For Cd4/Cd8 T Cells By Positive Immunoselection, Activated By Cd3 And Cd28 Agonists And Transduced With The Vector. Without Further Cell Propagation, The T Cells Are Washed, Formulated For Infusion, And Cryopreserved. The Substance Is Composed Of ?80% T Cells And ?1% B Cells, With A Mixture Of Transgene Positive (>3.4%) And Negative T Cells. The Cd4+ And Cd8+ Naïve T Cell Subsets (Cd45Ra+Ccr7+) Present In The Leukapheresis Material Are Largely Retained
Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals
P1/2
CC
(41)
Autologous T Cells Obtained From Peripheral Blood Mononuclear Cells By Leukapheresis, Transduced With A Self-Inactivating, Nonreplicating Lentiviral Vector, Encoding A T Cell Chimeric Antigen Receptor Targeting Cd19. The Expressed Transgene Comprises A Cd8? Leader Sequence, A Murine Anti-Cd19 Single Chain Variable Fragment (Scfv) Derived From The Mouse Hybridoma Fmc63, A Cd8? Hinge And Transmembrane Region, And A 4-1Bb (Cd137) And Cd3? (Tcr?) Signaling Domain And Is Under Control Of The Elongation Factor 1 Alpha (Ef1?) Promoter. The Construct Is Flanked By 5' And 3' Long Terminal Repeats (Ltrs) And Also Contains A ? Packaging Signal, A Rev Response Element (Rre), A Central Polypurine Tract (Cppt) Sequence And An Optimized Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element (Wpre). The Leukapheresis Material Is Enriched For Cd4/Cd8 T Cells By Positive Immunoselection, Activated By Cd3 And Cd28 Agonists And Transduced With The Vector. Without Further Cell Propagation, The T Cells Are Washed, Formulated For Infusion, And Cryopreserved. The Substance Is Composed Of ?80% T Cells And ?1% B Cells, With A Mixture Of Transgene Positive (>3.4%) And Negative T Cells. The Cd4+ And Cd8+ Naïve T Cell Subsets (Cd45Ra+Ccr7+) Present In The Leukapheresis Material Are Largely Retained
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Novartis Pharmaceuticals
P1/2
CC
(41)
Autologous Γδt Cells
Glioblastoma
In8bio Inc.
P1/2
CC
(41)
Car.70/Il15-Transduced Cb-Nk Cells
Hodgkins Lymphoma
M.D. Anderson Cancer Center
P1/2
CC
(41)
Showing 2076 to 2100 of 3,186 assets
Previous
Page 84 of 128
Next